- Home
- BBAR vs OGN Comparison
BBAR vs OGN Comparison
Compare BBAR & OGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BBAR
- OGN
- Stock Information
- Founded
- BBAR 1886
- OGN 1923
- Country
- BBAR Argentina
- OGN United States
- Employees
- BBAR N/A
- OGN N/A
- Industry
- BBAR Commercial Banks
- OGN Biotechnology: Pharmaceutical Preparations
- Sector
- BBAR Finance
- OGN Health Care
- Exchange
- BBAR Nasdaq
- OGN Nasdaq
- Market Cap
- BBAR 2.5B
- OGN 2.5B
- IPO Year
- BBAR N/A
- OGN N/A
- Fundamental
- Price
- BBAR $12.35
- OGN $10.39
- Analyst Decision
- BBAR Buy
- OGN Hold
- Analyst Count
- BBAR 1
- OGN 4
- Target Price
- BBAR $27.00
- OGN $18.00
- AVG Volume (30 Days)
- BBAR 715.8K
- OGN 3.8M
- Earning Date
- BBAR 08-20-2025
- OGN 10-30-2025
- Dividend Yield
- BBAR 0.18%
- OGN 0.77%
- EPS Growth
- BBAR N/A
- OGN N/A
- EPS
- BBAR 0.38
- OGN 2.69
- Revenue
- BBAR $1,945,235,030.00
- OGN $6,281,000,000.00
- Revenue This Year
- BBAR N/A
- OGN N/A
- Revenue Next Year
- BBAR $23.38
- OGN $1.36
- P/E Ratio
- BBAR $10.97
- OGN $3.86
- Revenue Growth
- BBAR N/A
- OGN N/A
- 52 Week Low
- BBAR $10.06
- OGN $8.01
- 52 Week High
- BBAR $25.01
- OGN $22.42
- Technical
- Relative Strength Index (RSI)
- BBAR 30.55
- OGN 66.34
- Support Level
- BBAR $11.58
- OGN $8.95
- Resistance Level
- BBAR $12.79
- OGN $9.64
- Average True Range (ATR)
- BBAR 0.79
- OGN 0.33
- MACD
- BBAR -0.16
- OGN 0.12
- Stochastic Oscillator
- BBAR 15.87
- OGN 97.96
About BBAR Banco BBVA Argentina S.A. ADS
Banco BBVA Argentina SA is a banking services provider in Argentina. It provides financial assistance to large corporations, small and medium-sized companies, as well as individuals. It bank provides services through retail, corporate, investment banking, and Small and medium-sized companies divisions. Through the retail banking segment, it provides banking products and services to individuals, corporate banking deals with services to corporates, and the small and medium-sized companies segment focuses on foreign trade, agricultural business, and digital products.
About OGN Organon & Co.
Organon & Co is a science-based pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. The Company's operations include the following product portfolio: Women's health, Biosimilars and Established medicines. Geographically, it derives a majority of its revenue from Europe and Canada followed by the United States and then Asia Pacific and Japan. The company generates the majority of its revenue from the Established Brands product portfolio.